Adnan Jehangir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adnan Jehangir has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Javed Iqbal Wani
Department of Internal Medicine, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
6 shared publications - Mohammad Muzaffar Mir
Department of Clinical Biochemistry, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
6 shared publications - Muffarah Hamid Alharthi
Department of Family and Community Medicine, College of medicine, University of Bisha, Bisha 61922, Saudi Arabia
6 shared publications - Rashid Mir
Prince Fahad Bin Sultan Chair for Biomedical Research, University of Tabuk
6 shared publications - Abdullah M. Alshahrani
Department of Family and Community Medicine, College of medicine, University of Bisha, Bisha 61922, Saudi Arabia
4 shared publications - Ayyub Ali Patel
Department of Clinical Biochemistry and Medical Education, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
4 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (5) , e70473
Topical Anesthetics Effectiveness in Management of Orthodontic Pain: A Systematic Review of Randomized Controlled Trials
Objectives: Orthodontic treatment can be associated with pain, particularly during separator placement, appliance insertion, or activation. Topical anesthetics may offer a simple, locally applied alternative to systemic analgesics, but their effectiveness remains uncertain. The objective of this review was to evaluate the efficacy of topical anesthetics, compared to other treatments or no treatment, in reducing orthodontic pain. Material and Methods: Eligible studies were randomized controlled trials (RCTs) comparing topical anesthetics (gels or patches) with placebo, no treatment, or other active pain‐control interventions in orthodontic patients. Five databases (PubMed, Scopus, Cochrane CENTRAL, Embase, Web of Science) were searched up to 14th March 2026, with no language or date restrictions. Data were extracted in duplicate, and the risk of bias was assessed using the ROB‐2 tool. Due to heterogeneity, only a qualitative synthesis was performed. Results: Nine RCTs (456 participants, mean age 14–35 years; 36.3% male) conducted in four countries were included. Benzocaine was the most investigated, followed by lidocaine, prilocaine/lidocaine, and menthol. Most studies examined separator‐induced pain. Eight of nine trials reported significant reductions in pain intensity with topical anesthetics at one or more time points, particularly within the first 24 to 72 h. Benzocaine consistently showed superior outcomes compared with placebo. Lidocaine and prilocaine/lidocaine provided rapid analgesia, especially in patients with high anxiety or low pain thresholds. Menthol patches also showed significant short‐term pain reduction in two studies. Risk of bias was moderate in most trials. Conclusion: Topical anesthetics can be effective in reducing short‐term orthodontic pain. Their use may reduce reliance on systemic analgesics and improve patient comfort during the initial stages of treatment. However, evidence quality remains limited, and further high‐quality RCTs with standardized protocols are needed.
- 6 October 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12 (5) , e70473
Open AccessTopical Anesthetics Effectiveness in Management of Orthodontic Pain: A Systematic Review of Randomized Controlled Trials
Objectives: Orthodontic treatment can be associated with pain, particularly during separator placement, appliance insertion, or activation. Topical anesthetics may offer a simple, locally applied alternative to systemic analgesics, but their effectiveness remains uncertain. The objective of this review was to evaluate the efficacy of topical anesthetics, compared to other treatments or no treatment, in reducing orthodontic pain. Material and Methods: Eligible studies were randomized controlled trials (RCTs) comparing topical anesthetics (gels or patches) with placebo, no treatment, or other active pain‐control interventions in orthodontic patients. Five databases (PubMed, Scopus, Cochrane CENTRAL, Embase, Web of Science) were searched up to 14th March 2026, with no language or date restrictions. Data were extracted in duplicate, and the risk of bias was assessed using the ROB‐2 tool. Due to heterogeneity, only a qualitative synthesis was performed. Results: Nine RCTs (456 participants, mean age 14–35 years; 36.3% male) conducted in four countries were included. Benzocaine was the most investigated, followed by lidocaine, prilocaine/lidocaine, and menthol. Most studies examined separator‐induced pain. Eight of nine trials reported significant reductions in pain intensity with topical anesthetics at one or more time points, particularly within the first 24 to 72 h. Benzocaine consistently showed superior outcomes compared with placebo. Lidocaine and prilocaine/lidocaine provided rapid analgesia, especially in patients with high anxiety or low pain thresholds. Menthol patches also showed significant short‐term pain reduction in two studies. Risk of bias was moderate in most trials. Conclusion: Topical anesthetics can be effective in reducing short‐term orthodontic pain. Their use may reduce reliance on systemic analgesics and improve patient comfort during the initial stages of treatment. However, evidence quality remains limited, and further high‐quality RCTs with standardized protocols are needed.
- 24 August 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-15
Efficacy and safety of intraperitoneal lidocaine in patients undergoing laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized clinical trials
Background Postoperative pain remains a significant clinical challenge following laparoscopic cholecystectomy (LC), with up to 80% of patients experiencing moderate to severe pain. Intraperitoneal (IP) lidocaine has emerged as a promising opioid-sparing analgesic technique, though evidence regarding its efficacy remains inconsistent. Aims To critically evaluate the analgesic efficacy and safety of intraperitoneal lidocaine compared with saline and intravenous lidocaine in patients undergoing laparoscopic cholecystectomy. Methods We included randomized controlled trials comparing IP lidocaine with saline or intravenous (IV) lidocaine in patients undergoing LC. We searched PubMed, Scopus, Web of Science, and Cochrane Library from inception to November 2025. Primary outcomes included early (0–8 h), late (24 h), and shoulder tip postoperative pain scores. Secondary outcomes comprised opioid consumption, hospital length of stay, and postoperative nausea and vomiting (PONV) incidence. Random-effects models were used for all analyses, with subgroup analyses based on lidocaine dosage. Results Eight randomized controlled trials involving 532 patients were included. Compared to saline, IP lidocaine significantly reduced early postoperative pain (MD = -1.06, 95% CI: -1.78 to -0.34, p = 0.004), late pain at 24 h (MD = -0.60, 95% CI: -1.00 to -0.21, p = 0.003), and shoulder tip pain (MD = -1.04, 95% CI: -1.82 to -0.26, p = 0.009). Total opioid consumption was significantly reduced (SMD = -3.68, 95% CI: -6.65 to -0.72, p = 0.01). No significant differences were observed in hospital length of stay or PONV incidence. When compared to IV lidocaine, IP administration showed no significant difference in early pain relief, but IV lidocaine demonstrated superior late pain control (MD = 1.99, 95% CI: 1.59 to 2.40, p < 0.00001) and longer time to first analgesic request (MD = -73.30 min, 95% CI: -98.65 to -47.95, p < 0.00001). Conclusion IP lidocaine provides significant pain relief and reduces opioid consumption following LC compared to placebo. While it offers comparable early analgesic effects to IV lidocaine, systemic administration provides superior sustained pain relief. IP lidocaine represents a safe, cost-effective adjunct for multimodal analgesia in LC, particularly for addressing shoulder tip pain.
- 24 August 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-15
Efficacy and safety of intraperitoneal lidocaine in patients undergoing laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized clinical trials
Background Postoperative pain remains a significant clinical challenge following laparoscopic cholecystectomy (LC), with up to 80% of patients experiencing moderate to severe pain. Intraperitoneal (IP) lidocaine has emerged as a promising opioid-sparing analgesic technique, though evidence regarding its efficacy remains inconsistent. Aims To critically evaluate the analgesic efficacy and safety of intraperitoneal lidocaine compared with saline and intravenous lidocaine in patients undergoing laparoscopic cholecystectomy. Methods We included randomized controlled trials comparing IP lidocaine with saline or intravenous (IV) lidocaine in patients undergoing LC. We searched PubMed, Scopus, Web of Science, and Cochrane Library from inception to November 2025. Primary outcomes included early (0–8 h), late (24 h), and shoulder tip postoperative pain scores. Secondary outcomes comprised opioid consumption, hospital length of stay, and postoperative nausea and vomiting (PONV) incidence. Random-effects models were used for all analyses, with subgroup analyses based on lidocaine dosage. Results Eight randomized controlled trials involving 532 patients were included. Compared to saline, IP lidocaine significantly reduced early postoperative pain (MD = -1.06, 95% CI: -1.78 to -0.34, p = 0.004), late pain at 24 h (MD = -0.60, 95% CI: -1.00 to -0.21, p = 0.003), and shoulder tip pain (MD = -1.04, 95% CI: -1.82 to -0.26, p = 0.009). Total opioid consumption was significantly reduced (SMD = -3.68, 95% CI: -6.65 to -0.72, p = 0.01). No significant differences were observed in hospital length of stay or PONV incidence. When compared to IV lidocaine, IP administration showed no significant difference in early pain relief, but IV lidocaine demonstrated superior late pain control (MD = 1.99, 95% CI: 1.59 to 2.40, p < 0.00001) and longer time to first analgesic request (MD = -73.30 min, 95% CI: -98.65 to -47.95, p < 0.00001). Conclusion IP lidocaine provides significant pain relief and reduces opioid consumption following LC compared to placebo. While it offers comparable early analgesic effects to IV lidocaine, systemic administration provides superior sustained pain relief. IP lidocaine represents a safe, cost-effective adjunct for multimodal analgesia in LC, particularly for addressing shoulder tip pain.
- Open Access
- 2 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5956
Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation
Prostate cancer remains one of the most biologically heterogeneous malignancies in men and continues to present major therapeutic challenges despite advances in androgen receptor-targeted therapy and molecular stratification. Increasing evidence suggests that prostate cancer progression is influenced not only by tumor-intrinsic genetic alterations but also by complex interactions involving androgen receptor signaling, inflammatory pathways, metabolic reprogramming, oxidative stress, epigenetic remodeling, immune dysregulation, and gut microbiome-associated signaling. Within this evolving systems-level framework, natural products have attracted increasing attention because of their ability to modulate multiple interconnected molecular pathways. This review examines the molecular basis of prostate cancer progression with particular emphasis on crosstalk among androgen receptor signaling, microbiome-associated regulation, epigenetic adaptation, inflammatory signaling, and tumor microenvironment remodeling. The emerging role of the gut microbiome in androgen metabolism, microbial metabolite production, immune regulation, and endocrine resistance is critically discussed, together with current evidence describing the biological effects of selected phytochemicals including curcumin, epigallocatechin-3-gallate, resveratrol, sulforaphane, quercetin, and genistein. These compounds may influence prostate cancer-associated pathways through modulation of inflammatory signaling, oxidative stress, metabolic adaptation, chromatin remodeling, and microbiome dynamics. Major translational limitations including poor bioavailability, pharmacokinetic variability, microbiome heterogeneity, inconsistent clinical evidence, and incomplete mechanistic understanding are additionally discussed. Rather than considering natural products as isolated anticancer agents, this review adopts a systems-level perspective in which dietary bioactive compounds may function as modulators of interconnected regulatory networks relevant to prostate cancer biology and therapeutic responsiveness.
- 2 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5956
Open AccessNatural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation
Prostate cancer remains one of the most biologically heterogeneous malignancies in men and continues to present major therapeutic challenges despite advances in androgen receptor-targeted therapy and molecular stratification. Increasing evidence suggests that prostate cancer progression is influenced not only by tumor-intrinsic genetic alterations but also by complex interactions involving androgen receptor signaling, inflammatory pathways, metabolic reprogramming, oxidative stress, epigenetic remodeling, immune dysregulation, and gut microbiome-associated signaling. Within this evolving systems-level framework, natural products have attracted increasing attention because of their ability to modulate multiple interconnected molecular pathways. This review examines the molecular basis of prostate cancer progression with particular emphasis on crosstalk among androgen receptor signaling, microbiome-associated regulation, epigenetic adaptation, inflammatory signaling, and tumor microenvironment remodeling. The emerging role of the gut microbiome in androgen metabolism, microbial metabolite production, immune regulation, and endocrine resistance is critically discussed, together with current evidence describing the biological effects of selected phytochemicals including curcumin, epigallocatechin-3-gallate, resveratrol, sulforaphane, quercetin, and genistein. These compounds may influence prostate cancer-associated pathways through modulation of inflammatory signaling, oxidative stress, metabolic adaptation, chromatin remodeling, and microbiome dynamics. Major translational limitations including poor bioavailability, pharmacokinetic variability, microbiome heterogeneity, inconsistent clinical evidence, and incomplete mechanistic understanding are additionally discussed. Rather than considering natural products as isolated anticancer agents, this review adopts a systems-level perspective in which dietary bioactive compounds may function as modulators of interconnected regulatory networks relevant to prostate cancer biology and therapeutic responsiveness.
- Open Access
- 17 June 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (6) , 116
Post-Levothyroxine Thyroid Dysfunction in Saudi Arabian Patients with Hypothyroidism: A Cross-Sectional Study
Background: Post-thyroxine treatment of thyroid dysfunction remains a clinical concern, especially in Middle Eastern populations. Methods: This descriptive cross-sectional study was conducted in 2023 at King Fahad Hospital, Hufof, Kingdom of Saudi Arabia. Of the 237 patients treated with L-thyroxine (L-T4) for hypothyroidism, 163 patients, almost exclusively females (152 females, 11 males), met the inclusion criteria and were enrolled. Thyroid hormones, lipid profiles, and 25-hydroxyvitamin D (25OH-D) were measured using standard laboratory assays. Results: Only 57% of patients achieved euthyroid status following L-T4 treatment, while 12.3% developed post-thyroxine-treatment (PTT) hyperthyroidism, and 30.7% developed PTT hypothyroidism. Older age was significantly associated with dysthyroidism (p = 0.018), whereas obesity (p = 0.937) and vitamin D levels (p = 0.982) were not. Total cholesterol (TC) and LDLc positively correlated with TSH levels, while elevated triglycerides (TGs) were significantly associated with PTT hyperthyroidism. The two dysthyroid subgroups were comparable across all non-thyroid parameters, including age, BMI, 25(OH)D levels, and lipid fractions. However, free T4 was significantly higher in PTT hyperthyroidism (p < 0.001); free T3 showed a trend toward higher levels in PTT hyperthyroidism (p = 0.052); and TSH was significantly higher in PTT hypothyroidism (p < 0.001). Conclusions: The proportions of patients with PTT hypo- and hyperthyroidism are aligned with international observations. Furthermore, the age was significantly associated with dysthyroidism, and dyslipidemia is the most consistent biochemical correlate of suboptimal thyroid status; however, the associations of PTT dysthyroidism with hypovitaminosis D and BMI were not noticed in this setting.
- 17 June 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (6) , 116
Open AccessPost-Levothyroxine Thyroid Dysfunction in Saudi Arabian Patients with Hypothyroidism: A Cross-Sectional Study
Background: Post-thyroxine treatment of thyroid dysfunction remains a clinical concern, especially in Middle Eastern populations. Methods: This descriptive cross-sectional study was conducted in 2023 at King Fahad Hospital, Hufof, Kingdom of Saudi Arabia. Of the 237 patients treated with L-thyroxine (L-T4) for hypothyroidism, 163 patients, almost exclusively females (152 females, 11 males), met the inclusion criteria and were enrolled. Thyroid hormones, lipid profiles, and 25-hydroxyvitamin D (25OH-D) were measured using standard laboratory assays. Results: Only 57% of patients achieved euthyroid status following L-T4 treatment, while 12.3% developed post-thyroxine-treatment (PTT) hyperthyroidism, and 30.7% developed PTT hypothyroidism. Older age was significantly associated with dysthyroidism (p = 0.018), whereas obesity (p = 0.937) and vitamin D levels (p = 0.982) were not. Total cholesterol (TC) and LDLc positively correlated with TSH levels, while elevated triglycerides (TGs) were significantly associated with PTT hyperthyroidism. The two dysthyroid subgroups were comparable across all non-thyroid parameters, including age, BMI, 25(OH)D levels, and lipid fractions. However, free T4 was significantly higher in PTT hyperthyroidism (p < 0.001); free T3 showed a trend toward higher levels in PTT hyperthyroidism (p = 0.052); and TSH was significantly higher in PTT hypothyroidism (p < 0.001). Conclusions: The proportions of patients with PTT hypo- and hyperthyroidism are aligned with international observations. Furthermore, the age was significantly associated with dysthyroidism, and dyslipidemia is the most consistent biochemical correlate of suboptimal thyroid status; however, the associations of PTT dysthyroidism with hypovitaminosis D and BMI were not noticed in this setting.
- Open Access
- 26 May 2026
- Published by MDPI AG in Preprints.org
Natural Products in Prostate Cancer: Crosstalk among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation
Prostate cancer remains one of the most biologically heterogeneous malignancies in men and continues to pose major clinical challenges despite substantial advances in diagnosis and treatment. Although androgen deprivation therapy and newer androgen receptor targeted agents have improved disease control, therapeutic resistance and progression to castration resistant prostate cancer remain common. Increasing evidence suggests that prostate cancer progression is influenced not only by tumor intrinsic genetic alterations, but also by complex interactions involving inflammatory signaling, metabolic reprogramming, oxidative stress, epigenetic regulation, immune dysfunction, and the gut microbiome. In parallel, interest has grown in the potential role of natural products as modulators of multiple interconnected biological pathways relevant to prostate cancer biology. This review examines the molecular mechanisms underlying prostate cancer progression with particular emphasis on androgen receptor signaling, PI3K/AKT and MAPK pathway activation, oxidative stress, lipid metabolism, inflammatory signaling, and epigenetic dysregulation. The emerging role of the gut microbiome in systemic androgen metabolism, immune regulation, microbial metabolite production, and inflammatory signaling is also discussed. In this context, the review evaluates current evidence describing the biological effects of selected natural products including curcumin, epigallocatechin gallate, resveratrol, quercetin, sulforaphane, genistein, and related phytochemicals that may influence tumor growth through modulation of microbiome composition, androgen receptor activity, inflammatory pathways, metabolic adaptation, and epigenetic regulation. Available translational and clinical evidence is critically examined together with important limitations related to bioavailability, pharmacokinetics, interindividual variability, microbiome heterogeneity, and incomplete mechanistic understanding. Rather than considering natural products as isolated therapeutic alternatives, this review adopts a systems level perspective in which dietary bioactive compounds may function as modulators of interconnected regulatory networks linking microbiome dynamics, metabolism, endocrine signaling, inflammation, and tumor biology. A more integrated understanding of these interactions may help inform future translational and precision based strategies in prostate cancer research.
- 26 May 2026
- Published by MDPI AG in Preprints.org
Open AccessNatural Products in Prostate Cancer: Crosstalk among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation
Prostate cancer remains one of the most biologically heterogeneous malignancies in men and continues to pose major clinical challenges despite substantial advances in diagnosis and treatment. Although androgen deprivation therapy and newer androgen receptor targeted agents have improved disease control, therapeutic resistance and progression to castration resistant prostate cancer remain common. Increasing evidence suggests that prostate cancer progression is influenced not only by tumor intrinsic genetic alterations, but also by complex interactions involving inflammatory signaling, metabolic reprogramming, oxidative stress, epigenetic regulation, immune dysfunction, and the gut microbiome. In parallel, interest has grown in the potential role of natural products as modulators of multiple interconnected biological pathways relevant to prostate cancer biology. This review examines the molecular mechanisms underlying prostate cancer progression with particular emphasis on androgen receptor signaling, PI3K/AKT and MAPK pathway activation, oxidative stress, lipid metabolism, inflammatory signaling, and epigenetic dysregulation. The emerging role of the gut microbiome in systemic androgen metabolism, immune regulation, microbial metabolite production, and inflammatory signaling is also discussed. In this context, the review evaluates current evidence describing the biological effects of selected natural products including curcumin, epigallocatechin gallate, resveratrol, quercetin, sulforaphane, genistein, and related phytochemicals that may influence tumor growth through modulation of microbiome composition, androgen receptor activity, inflammatory pathways, metabolic adaptation, and epigenetic regulation. Available translational and clinical evidence is critically examined together with important limitations related to bioavailability, pharmacokinetics, interindividual variability, microbiome heterogeneity, and incomplete mechanistic understanding. Rather than considering natural products as isolated therapeutic alternatives, this review adopts a systems level perspective in which dietary bioactive compounds may function as modulators of interconnected regulatory networks linking microbiome dynamics, metabolism, endocrine signaling, inflammation, and tumor biology. A more integrated understanding of these interactions may help inform future translational and precision based strategies in prostate cancer research.
- Open Access
- 24 February 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (1) , 27
Artificial Intelligence, Assessment Integrity, and Professionalism in Medical Education: Global Disruption and Lessons from the Gulf Cooperation Council Region
Artificial intelligence (AI), particularly generative AI, is rapidly reshaping medical education worldwide. While AI-enabled tools offer significant opportunities for personalized learning, feedback automation, and clinical reasoning support, they simultaneously challenge foundational principles of assessment integrity and professional conduct. Traditional assessment models—largely predicated on individual authorship, knowledge recall, and observable performance—are increasingly strained by AI systems capable of generating sophisticated responses, analyses, and clinical narratives. This disruption has prompted urgent reconsideration of what constitutes academic honesty, valid assessment, and professional identity formation in contemporary medical training. This article critically examines the intersection of AI, assessment integrity, and professionalism in medical education from a global perspective, with particular attention to the experiences and emerging lessons from the Gulf Cooperation Council (GCC). The GCC provides a distinctive context characterized by rapid digital transformation, centralized accreditation and licensing systems, high-stakes assessments, and strong sociocultural norms governing professional behavior. These features make the region an instructive case for understanding how medical education systems respond to AI-driven challenges at scale. The article employs a critical narrative and conceptual framework, positioning generative AI as a normative disruptor that necessitates a reevaluation of assessment validity, ethical accountability, and the construction of professional identity. Utilizing worldwide scholarship, policy frameworks, and regional experiences, the analysis underscores that misalignment between assessment design and professional expectations jeopardizes trust, fairness, and public confidence. The essay advocates for a transition from reactive restriction to the principled integration of AI, highlighting the need for assessment redesign, AI literacy matched with professionalism, teacher development, and cohesive governance. These insights are intended to guide educators, institutions, and regulators in maintaining professional standards inside AI-enhanced medical education systems.
- 24 February 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (1) , 27
Open AccessArtificial Intelligence, Assessment Integrity, and Professionalism in Medical Education: Global Disruption and Lessons from the Gulf Cooperation Council Region
Artificial intelligence (AI), particularly generative AI, is rapidly reshaping medical education worldwide. While AI-enabled tools offer significant opportunities for personalized learning, feedback automation, and clinical reasoning support, they simultaneously challenge foundational principles of assessment integrity and professional conduct. Traditional assessment models—largely predicated on individual authorship, knowledge recall, and observable performance—are increasingly strained by AI systems capable of generating sophisticated responses, analyses, and clinical narratives. This disruption has prompted urgent reconsideration of what constitutes academic honesty, valid assessment, and professional identity formation in contemporary medical training. This article critically examines the intersection of AI, assessment integrity, and professionalism in medical education from a global perspective, with particular attention to the experiences and emerging lessons from the Gulf Cooperation Council (GCC). The GCC provides a distinctive context characterized by rapid digital transformation, centralized accreditation and licensing systems, high-stakes assessments, and strong sociocultural norms governing professional behavior. These features make the region an instructive case for understanding how medical education systems respond to AI-driven challenges at scale. The article employs a critical narrative and conceptual framework, positioning generative AI as a normative disruptor that necessitates a reevaluation of assessment validity, ethical accountability, and the construction of professional identity. Utilizing worldwide scholarship, policy frameworks, and regional experiences, the analysis underscores that misalignment between assessment design and professional expectations jeopardizes trust, fairness, and public confidence. The essay advocates for a transition from reactive restriction to the principled integration of AI, highlighting the need for assessment redesign, AI literacy matched with professionalism, teacher development, and cohesive governance. These insights are intended to guide educators, institutions, and regulators in maintaining professional standards inside AI-enhanced medical education systems.
- Open Access
- 13 January 2026
- Published by MDPI AG in Preprints.org
Artificial Intelligence, Assessment Integrity, and Professionalism in Medical Education: Global Disruption and Lessons from the Gulf Cooperation Council Region
Artificial intelligence (AI), particularly generative AI, is rapidly reshaping medical education worldwide. While AI-enabled tools offer significant opportunities for personalized learning, feedback automation, and clinical reasoning support, they simultaneously challenge foundational principles of assessment integrity and professional conduct. Traditional assessment models—largely predicated on individual authorship, knowledge recall, and observable performance are increasingly strained by AI systems capable of generating sophisticated responses, analyses, and clinical narratives. This disruption has prompted urgent reconsideration of what constitutes academic honesty, valid assessment, and professional identity formation in contemporary medical training. This article critically examines the intersection of AI, assessment integrity, and professionalism in medical education from a global perspective, with particular attention to the experiences and emerging lessons from the Gulf Cooperation Council (GCC). The GCC provides a distinctive context characterized by rapid digital transformation, centralized accreditation and licensing systems, high-stakes assessments, and strong sociocultural norms governing professional behavior. These features make the region an instructive case for understanding how medical education systems respond to AI-driven challenges at scale. Drawing on international literature, policy documents, and regional practices, this paper argues that AI should be understood not merely as a technological tool but as a normative disruptor that compels a re-examination of assessment validity, ethical responsibility, and professional identity. The article proposes a shift from reactive prohibition toward principled integration of AI within assessment and professionalism frameworks. It concludes by outlining future-oriented recommendations for educators, institutions, and regulators aimed at preserving trust, fairness, and professional standards in an AI-augmented educational landscape.
- 13 January 2026
- Published by MDPI AG in Preprints.org
Open AccessArtificial Intelligence, Assessment Integrity, and Professionalism in Medical Education: Global Disruption and Lessons from the Gulf Cooperation Council Region
Artificial intelligence (AI), particularly generative AI, is rapidly reshaping medical education worldwide. While AI-enabled tools offer significant opportunities for personalized learning, feedback automation, and clinical reasoning support, they simultaneously challenge foundational principles of assessment integrity and professional conduct. Traditional assessment models—largely predicated on individual authorship, knowledge recall, and observable performance are increasingly strained by AI systems capable of generating sophisticated responses, analyses, and clinical narratives. This disruption has prompted urgent reconsideration of what constitutes academic honesty, valid assessment, and professional identity formation in contemporary medical training. This article critically examines the intersection of AI, assessment integrity, and professionalism in medical education from a global perspective, with particular attention to the experiences and emerging lessons from the Gulf Cooperation Council (GCC). The GCC provides a distinctive context characterized by rapid digital transformation, centralized accreditation and licensing systems, high-stakes assessments, and strong sociocultural norms governing professional behavior. These features make the region an instructive case for understanding how medical education systems respond to AI-driven challenges at scale. Drawing on international literature, policy documents, and regional practices, this paper argues that AI should be understood not merely as a technological tool but as a normative disruptor that compels a re-examination of assessment validity, ethical responsibility, and professional identity. The article proposes a shift from reactive prohibition toward principled integration of AI within assessment and professionalism frameworks. It concludes by outlining future-oriented recommendations for educators, institutions, and regulators aimed at preserving trust, fairness, and professional standards in an AI-augmented educational landscape.
- Open Access
- 27 November 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 442
Low estimated glucose disposal rate predicts high residual syntax score in non-diabetic ST-elevation myocardial infarction patients
Insulin resistance (IR) plays a significant role in the development of cardiovascular disease (CVD), even in non-diabetic individuals, with a 46% higher li
- 27 November 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 442
Open AccessLow estimated glucose disposal rate predicts high residual syntax score in non-diabetic ST-elevation myocardial infarction patients
Insulin resistance (IR) plays a significant role in the development of cardiovascular disease (CVD), even in non-diabetic individuals, with a 46% higher li
- Open Access
- 19 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2770
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Insulin resistance (IR) is a significant factor in the development and progression of metabolic-related diseases like dyslipidemia, T2DM, hypertension, nonalcoholic fatty liver disease, cardiovascular and cerebrovascular disorders, and cancer. The pathogenesis of IR depends on multiple factors, including age, genetic predisposition, obesity, oxidative stress, among others. Abnormalities in the insulin-signaling cascade lead to IR in the host, including insulin receptor abnormalities, internal environment disturbances, and metabolic alterations in the muscle, liver, and cellular organelles. The complex and multifaceted characteristics of insulin signaling and insulin resistance envisage their thorough and comprehensive understanding at the cellular and molecular level. Therapeutic strategies for IR include exercise, dietary interventions, and pharmacotherapy. However, there are still gaps to be addressed, and more precise biomarkers for associated chronic diseases and lifestyle interventions are needed. Understanding these pathways is essential for developing effective treatments for IR, reducing healthcare costs, and improving quality of patient life.
- 19 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2770
Open AccessUnraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Insulin resistance (IR) is a significant factor in the development and progression of metabolic-related diseases like dyslipidemia, T2DM, hypertension, nonalcoholic fatty liver disease, cardiovascular and cerebrovascular disorders, and cancer. The pathogenesis of IR depends on multiple factors, including age, genetic predisposition, obesity, oxidative stress, among others. Abnormalities in the insulin-signaling cascade lead to IR in the host, including insulin receptor abnormalities, internal environment disturbances, and metabolic alterations in the muscle, liver, and cellular organelles. The complex and multifaceted characteristics of insulin signaling and insulin resistance envisage their thorough and comprehensive understanding at the cellular and molecular level. Therapeutic strategies for IR include exercise, dietary interventions, and pharmacotherapy. However, there are still gaps to be addressed, and more precise biomarkers for associated chronic diseases and lifestyle interventions are needed. Understanding these pathways is essential for developing effective treatments for IR, reducing healthcare costs, and improving quality of patient life.
- Open Access
- 24 February 2025
- Published by MDPI AG in Preprints.org
Unraveling The Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Insulin resistance (IR) is a significant factor in the development and progression of metabolic-related diseases like dyslipidemia, T2DM, hypertension, nonalcoholic fatty liver disease, cardiovascular and cerebrovascular disorders and cancer. The pathogenesis of IR depends on multiple factors including age, genetic predisposition, obesity, oxidative stress and other factors. Abnormalities in the insulin signaling cascade lead to IR in the host, including insulin receptor abnormalities, internal environment disturbances, and metabolic alterations in the muscle, liver and cellular organelles. The complex and multifaceted characteristics of insulin signaling and insulin resistance envisage its thorough and comprehensive understanding at the cellular and molecular level. Therapeutic strategies for IR include exercise, dietary interventions and pharmacotherapy. However, there are still gaps to be addressed, and more precise biomarkers for associated chronic diseases and lifestyle interventions are needed. Understanding these pathways is essential for developing effective treatments for IR, reducing healthcare costs and improving quality of patient life.
- 24 February 2025
- Published by MDPI AG in Preprints.org
Open AccessUnraveling The Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Insulin resistance (IR) is a significant factor in the development and progression of metabolic-related diseases like dyslipidemia, T2DM, hypertension, nonalcoholic fatty liver disease, cardiovascular and cerebrovascular disorders and cancer. The pathogenesis of IR depends on multiple factors including age, genetic predisposition, obesity, oxidative stress and other factors. Abnormalities in the insulin signaling cascade lead to IR in the host, including insulin receptor abnormalities, internal environment disturbances, and metabolic alterations in the muscle, liver and cellular organelles. The complex and multifaceted characteristics of insulin signaling and insulin resistance envisage its thorough and comprehensive understanding at the cellular and molecular level. Therapeutic strategies for IR include exercise, dietary interventions and pharmacotherapy. However, there are still gaps to be addressed, and more precise biomarkers for associated chronic diseases and lifestyle interventions are needed. Understanding these pathways is essential for developing effective treatments for IR, reducing healthcare costs and improving quality of patient life.